matoses. Importantly, these findings were demonstrated with
the clocortolone pivalate 0.1% cream containing the active TCS
ingredient and not just with the cream vehicle alone. These results
were confirmed in a second study of the same design.
Efficacy and Safety Data
Clocortolone pivalate 0.1% cream has been studied in multiple
clinical trials for the treatment of a variety of CRDs. These trials
were inclusive of 559 adult and pediatric patients who were ac-